GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sibannac Inc (OTCPK:SNNC) » Definitions » EV-to-EBIT

Sibannac (Sibannac) EV-to-EBIT : -4.70 (As of May. 06, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Sibannac EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Sibannac's Enterprise Value is $0.54 Mil. Sibannac's EBIT for the trailing twelve months (TTM) ended in Feb. 2017 was $-0.12 Mil. Therefore, Sibannac's EV-to-EBIT for today is -4.70.

The historical rank and industry rank for Sibannac's EV-to-EBIT or its related term are showing as below:

SNNC's EV-to-EBIT is not ranked *
in the Drug Manufacturers industry.
Industry Median: 17.86
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Sibannac's Enterprise Value for the quarter that ended in Feb. 2017 was $4.18 Mil. Sibannac's EBIT for the trailing twelve months (TTM) ended in Feb. 2017 was $-0.12 Mil. Sibannac's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Feb. 2017 was -2.75%.


Sibannac EV-to-EBIT Historical Data

The historical data trend for Sibannac's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sibannac EV-to-EBIT Chart

Sibannac Annual Data
Trend Aug11 Aug12 Aug13 Aug14 Aug15 Aug16
EV-to-EBIT
Get a 7-Day Free Trial - - -537.13 -2.57 -13.11

Sibannac Quarterly Data
May12 Aug12 Nov12 Feb13 May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Aug16 Nov16 Feb17
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -1.15 - - -

Competitive Comparison of Sibannac's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Sibannac's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sibannac's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sibannac's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Sibannac's EV-to-EBIT falls into.



Sibannac EV-to-EBIT Calculation

Sibannac's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=0.540/-0.115
=-4.70

Sibannac's current Enterprise Value is $0.54 Mil.
Sibannac's EBIT for the trailing twelve months (TTM) ended in Feb. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.12 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sibannac  (OTCPK:SNNC) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Sibannac's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Feb. 2017 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Feb. 2017 ) =EBIT / Enterprise Value (Q: Feb. 2017 )
=-0.115/4.182984
=-2.75 %

Sibannac's Enterprise Value for the quarter that ended in Feb. 2017 was $4.18 Mil.
Sibannac's EBIT for the trailing twelve months (TTM) ended in Feb. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.12 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sibannac EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Sibannac's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Sibannac (Sibannac) Business Description

Traded in Other Exchanges
N/A
Address
9535 E. Doubletree Ranch Road, Ste 120, Scottsdale, AZ, USA, 85258
Sibannac Inc is a cannabis research and development company. Its product portfolio includes Hemp oil and Peppermint CBD Mints. The company currently manufactures its CBD products in its new facility in Scottsdale, Arizona.

Sibannac (Sibannac) Headlines

From GuruFocus